Skip to content

Dr. AVG

Active
Private limited companyfounded 20196 yrs activeBovenboslaan 33, 3740 Bilzen-Hoeselt, BelgiumKBO/BCE: BE 0738.605.312
Summary

Dr. AVG has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €280,976 and a net result of €244,329. Equity remains stable across the filed fiscal years (±1.2% per year). Its solvency ranks better than 31% of 20272 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Risk analysisWatch ReportCompare
Dr. AVGActiveChecked score 96/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
3 sites
Size
€734,244total assets 2025
Equity
€280,976
Profit
€244,329
Turnover not published (abridged schema)
Financial health
96 Excellent Checked score 2025
Bankruptcy chance 12 m
< 0.1%
Structure
Accounts 133 d early0 of 1 deed read
Why 96+ Sector Human health activities (NACE 86)+ Liquidity: current ratio 3.16, cash €503,171+ Size: total assets €734,244+ Figures for FY 2025 (filed 25-03-2026)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Better than 64% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Strong
Solvency 63-5
equity 38.3% of total assets
Liquidity 86+15
short-term debt 31.6% · cash 68.5%
Profitability 100=
return on assets 33.3%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,748 companies)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● 0.0% vs 11-2024lowest value 01-2025: < 0.1%● 0.0% vs 12-2024lowest value 02-2025: < 0.1%● 0.0% vs 01-2025lowest value 03-2025: < 0.1%▲ +5.0% vs 02-2025 04-2025: < 0.1%● 0.0% vs 03-2025 05-2025: < 0.1%▲ +4.8% vs 04-2025 06-2025: < 0.1%● 0.0% vs 05-2025 07-2025: < 0.1%▲ +9.1% vs 06-2025 08-2025: < 0.1%▲ +16.7% vs 07-2025 09-2025: < 0.1%● 0.0% vs 08-2025 10-2025: < 0.1%▲ +3.6% vs 09-2025 11-2025: < 0.1%● 0.0% vs 10-2025 12-2025: < 0.1%● 0.0% vs 11-2025 01-2026: < 0.1%● 0.0% vs 12-2025 02-2026: < 0.1%● 0.0% vs 01-2026 03-2026: < 0.1%▲ +3.4% vs 02-2026highest value 04-2026: < 0.1%▼ -26.7% vs 03-2026 05-2026: < 0.1%● 0.0% vs 04-2026 06-2026: < 0.1%● 0.0% vs 05-2026 07-2026: < 0.1%● 0.0% vs 06-2026 08-2026: < 0.1%● 0.0% vs 07-2026 09-2026: < 0.1%● 0.0% vs 08-2026 10-2026: < 0.1%● 0.0% vs 09-2026
  • Sector Human health activities (NACE 86) lowers the probability
  • Liquidity: current ratio 3.16, cash €503,171 lowers the probability
  • Size: total assets €734,244 lowers the probability for this profile
  • Figures for FY 2025 (filed 25-03-2026) lowers the probability
Credit up to €25,000 at 30 days acceptable
Liquidity ample (current ratio 3.16 against 1.78 in 2024; short-term debt: 31.6% and cash: 68.5% of total assets), but 61.7% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 32%, liquidity 70%, profitability 80%, growth against the median 75%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Sector Human health activities (NACE 86)
In the bankruptcy model this factor lowers the probability.
KBO
lowers risk · Liquidity: current ratio 3.16, cash €503,171
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Size: total assets €734,244
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
lowers risk · Figures for FY 2025 (filed 25-03-2026)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-03-2026, 133 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
133 d early
2024
7 d early
2023
7 d early
2022
7 d early
2021
4 d early
2020
18 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 29 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 24 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
04-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Annual accounts filedfiscal year 2024 · micro…
  3. Annual accounts filedfiscal year 2023 · micro…

Key points

  • Positive: Among the best 8% on net resultsector median €60,272 · 20,260 companies €244,329 View
  • Positive: Always filed on timeaccounts within the deadline every year 6 years View
  • Positive: 6 profitable years in a rowprofit 2025: €244,329 6 years View
  • Positive: Equity rose in 2025from €206,647 to €280,976 ▲ 36.0% View

By topic

Financials

Fiscal year
2025
Total assets
€734,244
Profit
€244,329
Solvency
38.3%
Total assets▲ 51.8%
Net result
20202025
Go to Financials

Timeline

Events
11
Since
2021
Next accounts
by 31-07-2027
  1. 20-03-2026Annual accounts filed
  2. 24-07-2025Annual accounts filed
  3. 24-07-2024Annual accounts filed
Go to Timeline

Company details

Sites
3
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
01-12-2019
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure